Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Pharmather Holdings Ltd
PHRRF
Primary Symbol:
C.PHRM
psychedelics
PharmaTher Holdings Ltd. is a Canada-based specialty pharmaceutical company. The Company develops and commercializes specialty pharmaceuticals exhibiting growing adoption and permitting delivery methods to enhance patient outcomes. Its lead product is KETARX (racemic ketamine) to fill the global unmet medical needs for anesthesia, sedation, pain, mental health, and neurological indications. The...
Company is also commercializing PharmaPatch (microneedle patch) with its partners to deliver psychedelics and drugs to treat infectious diseases.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (CSE:PHRM)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
Next
(433)
•••
AwareInvestor
X
View Profile
View Bullboard History
Post by
AwareInvestor
on May 25, 2021 9:01am
PharmaTher Files With FDA For Orphan Drug Designation In Use
PharmaTher Holdings this morning announced that it has filed with the US FDA for orphan drug designation as it works to further study the uses of ketamine. The latest filing pertains to the use of
...more
(22)
•••
Eagles1968
X
View Profile
View Bullboard History
Comment by
Eagles1968
on May 19, 2021 4:12pm
RE:Load up people...
Anyone hearing anything about Orphan drug status?????
(36)
•••
GustheGreek
X
View Profile
View Bullboard History
Post by
GustheGreek
on May 19, 2021 1:08pm
Load up people...
Thus one's ready for a nice run. I'm betting it'll pop and surpass it's year high in the next few sessions.
(433)
•••
AwareInvestor
X
View Profile
View Bullboard History
Post by
AwareInvestor
on May 17, 2021 9:16am
PharmaTher Receives FDA Approval For Ketamine Trial For Park
PharmaTher Holdings has seen the US FDA approve the firms application for an investigational new drug. The approval relates to a phase 2 clinical trial to evaluate the use of ketamine in the treatment
...more
(140)
•••
INVESTigator1
X
View Profile
View Bullboard History
Post by
INVESTigator1
on May 07, 2021 3:04pm
TGIFF 1933 Industries - Nevada dispensaries everywhere...
Deliveries of flower, concentrates, badder, diamonds, exotics, crumble, pre-rolls, disposable vapes, CBDs & more... Can't keep track anymore this year: Penetration is getting real!!! And
...more
(433)
•••
AwareInvestor
X
View Profile
View Bullboard History
Post by
AwareInvestor
on Apr 27, 2021 7:55am
PharmaTher Files Patent For Use Of Ketamine In Type 2 Diabet
PharmaTher Holdingshas expanded its patent portfolio. The company this morning announced the filing of a provisional patent application in the US for the novel use of ketamine as a potential treatment
...more
(36)
•••
GustheGreek
X
View Profile
View Bullboard History
Comment by
GustheGreek
on Apr 21, 2021 5:21pm
RE:PharmaTher Submits For Phase 2 Clinical Trial With FDA
Market cap should be 10X where it is right now. Give it a month or two and pop this goes, maybe sooner.
(433)
•••
AwareInvestor
X
View Profile
View Bullboard History
Post by
AwareInvestor
on Apr 20, 2021 7:38am
PharmaTher Submits For Phase 2 Clinical Trial With FDA
PharmaTher Holdings is looked to complete a phase two clinical trial. The company this morning announced the submittal of an investigational new drug application with the US FDA for its drug focused
...more
(12)
•••
mrgreen0
X
View Profile
View Bullboard History
Post by
mrgreen0
on Apr 16, 2021 9:44am
Cant trade shares?
Anyine else
(9)
•••
doysen
X
View Profile
View Bullboard History
Post by
doysen
on Mar 28, 2021 1:05pm
Phrm
Most undervalued psychedelics play crazy valuation
(433)
•••
AwareInvestor
X
View Profile
View Bullboard History
Post by
AwareInvestor
on Mar 24, 2021 7:19am
PharmaTher Sponsors Research For Novel Delivery Of Ketamine
PharmaTher this morning announced that it has entered into a sponsored research agreement. The agreement, which was signed with The Queen’s University of Belfast, will see the development of a
...more
(12)
•••
mrgreen0
X
View Profile
View Bullboard History
Post by
mrgreen0
on Mar 16, 2021 9:18pm
17 mil mcap
And phrm has 7 mil in cash .4 mil shares of revive therapeutic.phase 2 ketamine for few approval coming. Biotech company with low outstanding shares of 69mil.
(220)
•••
IceColdBeer
X
View Profile
View Bullboard History
Post by
IceColdBeer
on Mar 09, 2021 1:07pm
Is it time yet?
It's pretty quiet here.....hmmmmm
(42)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Mar 02, 2021 8:07am
$PHRM - Update
https://stockhouse.com/news/press-releases/2021/03/02/pharmather-expands-to-neuromuscular-diseases-with-exclusive-license-agreement
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
LISTEN to the Jetstream #1 HELIUM appraisal well roar! Flow & Pressure Build-Up Tests Commence